Family Medicine & Medical Science Research

Family Medicine & Medical Science Research
Open Access

ISSN: 2327-4972

+44-77-2385-9429

Review Article - (2014) Volume 3, Issue 2

Management of Infected Orthopedic Joint Implants: Pertinent Information for Family Medicine Physicians

Gomez MM1, Manrique J1 and Chen AF2*
1Research Department, Rothman Institute, USA
2Department of Orthopaedics, Rothman Institute, USA
*Corresponding Author: Chen AF, Department of Orthopaedics, Rothman Institute, USA, Tel: 267-339-7813 Email:

Abstract

Periprosthetic joint infections (PJIs) are one of the most devastating complications after total joint replacement. An early diagnosis can improve the outcome of treating PJI, and the first steps for diagnosing PJI are often conducted by a family doctor or a general practitioner.

When a patient presents with a suspicion for PJI, the steps that must be followed are based on the clinical practice guideline by the American Academy of Orthopedic Surgeons (AAOS). Clinical symptoms, such as pain, are the main complaint that alerts physicians to a potential PJI, along with other symptoms such as erythema, warmth and tenderness around the surgical wound. These patients should receive x-rays of the affected joint, and laboratory tests such as erythrocyte sedimentation rate and C-reactive protein should be drawn. Physicians should actively avoid starting antibiotic therapy, obtaining nuclear medicine imaging, sending patients to infectious disease, or prescribing physical therapy. Finally, patients with a suspicion for PJI must be referred to an orthopedic surgeon who can establish the final diagnosis and conduct appropriate treatment.

<

Keywords: Joint implants; Family medicine; Physicians

Introduction

Total joint arthroplasty (TJA) is one of the most successful elective procedures in medicine. They are cost effective and offer a positive impact on the quality of life of patients [1,2], improving function and range of motion, while reducing pain. Survival of total hip arthroplasties (THAs) at 10 year follow up is greater than 95% [3], and at 25 year follow-up is up to 81% [4]. THAs and total knee arthroplasties are considered successful procedures in up to 90% of the patients even 20 years after the procedure [5]. This affirms Dr. Mark Coventry's famous statement in 1991; "THA, indeed, might be the orthopedic operation of the century" [6,7]. Currently, more than 500,000 TJAs are performed each year in the USA and UK [8,9]. By 2030, these values are expected to rise by 174% for THA and 673% for primary TKA [9].

Unfortunately, TJA is not exempt from complications, including periprosthetic joint infections (PJIs). It is the main cause for revision surgery and readmission during the first 90 days after surgery [10]. The incidence of PJI is 0.46% for total knee arthroplasty (TKA) and 0.33% for THA [11]. The development of PJI leads to complicated revision surgery, can compromise the functional outcome of the patient [12], and can dramatically increase health care costs. Currently, the cost of treating PJI is 4.8 times greater than the cost of THA [13]. By 2015, hospital charges for all revisions are projected to increase by 450%, up to $4.1 billion dollars [14].

Many patients presenting with PJI are initially assessed by a family practice physician or a general practitioner. Thus, these physicians are at the forefront of diagnosing PJI and can prevent complications associated with mismanagement of treating these patients. The purpose of this review is to elucidate the correct steps to be followed when faced with a potential case of PJI to minimize and to enhance patient treatment.

Clinical Symptoms of PJI

The most common presenting symptom in the setting of PJI is pain. For THA, the pain is generally located in the groin, and occasionally radiates to the buttocks. In TKA patients, these patients often experience global knee pain. Increased pain at night and limping due to pain are additional signs. Ordinarily, pain is constant and is unrelated to changes in physical activity. The presence of erythema, warmth and tenderness around the surgical wound do not necessary mean that a patient is infected. However, these symptoms should alert the clinician to a possible PJI. On the other hand, the presence of a draining sinus around the surgical wound is a major diagnosis criteria for PJI and must be treated as such [15]. These patients should be sent to an orthopedic surgeon immediately.

In patients with PJI, there is usually no fever or systemic compromise, unless there is an acute infection from hematogenous seeding of bacteria. Generally, PJI are frequently caused by low virulence, slow growing microorganisms [16]. These joint implant infections are often not life-threatening; however, these infections are very difficult to eradicate as bacteria form a protective coating around the implant, called a biofilm. This is developed as a defense mechanism used by certain pathogens to protect themselves and increase resistance to antibiotics.

There is no objective measure that can replace clinical suspicion as the starting and main point for the diagnosis of PJI. It must be combined with a thorough physical examination: evaluation of the surgical site, drainage or fistulas, and local signs of infection (redness, swelling, local erythema, pain and loss of function). Assessment of the patient’s range of motion, presence of pain, and gait pattern are all important and play a role in the diagnosis of PJI. Occurrence of limb length discrepancy without surgical intervention may be a late finding in chronic infection due to implant collapse. Clinical findings must be complimented with appropriate sets of tests and images.

A uniform definition of PJI was developed by the Musculoskeletal Infection Society (MSIS), which gathered experts in the field including orthopedic surgeons and infectious disease specialists. PJI occurs when there is one of two major criteria, or 4 of 6 minor criteria (Table 1) [15]. It is important to note that PJI may be present with less than 4 minor criteria, clinical judgment and individualization of each case is critical in identifying patients with PJI.

Major criteria:
Organisms cultured from two separate sites
Draining sinus track
Minor criteria:
Elevated erythrocyte sedimentation rate and serum C-reactive protein
Elevated joint synovial white blood cell count from joint aspirate
Elevated joint neutrophil percentage
A single positive culture of periprosthetic tissue
Elevated neutrophil count on periprosthetic tissue histologic analysis
Intra-articular purulence

Table 1: MSIS definition of PJI

Laboratory Tests

Even with standardized criteria, the laboratory diagnosis of PJI remains a challenge since there is no gold standard for diagnosis. Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) have long been the initial screening tests for the diagnosis of PJI. These lab tests are cost-effective, technically non-demanding, and have good sensitivity for detecting deep infection. The sensitivity and specificity of the ESR varies from 64% to 100% and 56% and 87%, respectively [16-19]. The sensitivity of ESR was reported to be 75% and the specificity 70% using a cut-off value of 30 mm/hr [20]. CRP has a sensitivity ranging from 71% to 94% and specificity from 71% to 86% [17-20]. As a result, these are tests used to "rule out" infection and when both tests are negative, the likelihood of infection is very low (negative likelihood ratio 0 to 0.06). If both tests are positive, the probability of infection is not negligible (positive likelihood ratio 4.3 to 12.1) [21] and the patient requires further investigation by a specialist. Unfortunately, several inflammatory pathologies can alter the results and lead to false positives. The routine use of CRP and ESR are used to rule out infection and are strongly recommended for aiding in the diagnosis of PJI [21].

Serum white blood cell (WBC) and specifically polymorphonuclear (PMN) cell count have been found to lack value in the diagnosis of PJI. In fact, these laboratory tests are not taken into consideration for the definition of PJI, nor the clinical practice guideline for the diagnosis of PJI from the American Academy of Orthopaedic Surgeons (AAOS) [21]. Many systemic diseases and inflammatory conditions may alter the results and therefore skew the test. The sensitivity for WBC is 55% and specificity is 66%. PMN sensitivity is 52% and specificity is 75%. These tests are not considered useful in the diagnosis or monitoring of PJI, and are not recommended as part of workup [22].

Radiographs

It is recommended that a set of plain x-rays are ordered, including anterior-posterior and lateral views of the affected joint when weight-bearing. It is also helpful to take a pelvis x-ray in THA patients. These radiographs are important to obtain but will not be the sole method of diagnosis. The purpose of obtaining x-rays is to assess the overall state of the implant and the bone surrounding it. Radiographic findings consistent with chronic cases of PJI are loosening, loss of bone stock, new bone reaction, endosteal scalloping, and migration of the components (Figure 1A and 1B). Radiographs are also important as a follow-up tool to compare to previous x-rays. While radiographs are not as helpful for diagnosing infection, they can rule out other causes of joint pain, including fractures or dislocations. There is no need for additional imaging in the primary care setting, and CT scans or MRI is not recommended to be ordered for diagnosing PJI [21,23].

family-medicine-medical-science-research-joint-infection-Loosening

Figure 1A and 1B: Radiographic changes found in periprosthetic joint infection. Loosening of the prosthesis and bone resorption can be seen in the femur around the prosthesis

What not to do

Do not underestimate the patient’s symptoms

Pain may be the only presenting clinical sign for acute or chronic cases of PJI. Classic symptoms of infection are not always present in the early stages of PJI. Night pain, continuous oppressive pain, rest pain, and pain either in the groin, thigh, or knee are all reasons to suspect a PJI, whether or not obvious symptoms of infection are present. Screening laboratory tests for infection using CRP and ESR should be done, as well as radiographs of the involved joint. If the results of ESR and CRP are negative for infection, the likelihood of PJI is very low. If the laboratory tests are elevated without a cause for infection, patients should be referred to an orthopedic surgeon. In addition, surgical options and the future of the joint should be addressed by an orthopedic surgeon.

Do not give antibiotics

Antibiotics should not be given as soon as PJI is suspected, as this mistake could prevent patients from receiving a reliable diagnosis of infection. The administration of antibiotics can lead to negative cultures from aspirations and deep cultures, hindering the final diagnosis of PJI [24]. In fact, preoperative antibiotics may decrease the sensitivity of cultures from 76.9% to 41.2% [23]. Negative cultures pose a challenge to the interdisciplinary team treating patients with PJI, as these patients are not able to receive targeted antibiotic therapy and usually receive broad-spectrum antibiotics or more than one antibiotic against common pathogens. Broad-spectrum treatment is associated with complications, including diarrhea (3-8%), pseudomembranous colitis (1%), delayed hypersensitivity reaction (11%), nephrotoxicity (due to vancomycin 1%), leukopenia (1%), and skin discoloration (due to minocycline, 1%) [25-27]. Thus, we encourage that antibiotics not be administered prior to seeing an orthopaedic surgeon and receiving treatment, so that the correct organism can be identified and tailored antibiotic treatment may be provided to the PJI patient.

Only order essential tests

Initial screening test recommendations by the AAOS Clinical Practice Guidelines include CRP, ESR, and a set of anterior-posterior and lateral radiograph views of the affected joint. This adds to the risk of stratification of each patient [21]. However, clinical judgment is paramount for guiding the diagnosis of PJI.

Further imaging beyond x-rays is not recommended. Nuclear medicine scans are an option, only when the diagnosis of PJI is confounding. It is important to note that nuclear medicine images may remain positive in the first postoperative year, and could be the source of false-positive results. Nuclear medicine tests can be helpful for ruling out infection, although a positive test may not add much to the work up. MRI and CT have limited use in the diagnosis of PJI and are often not included in the workup due to insufficient evidence to support these other imaging modalities [21].

Do not refer patients to infections disease

Once the initial screening of PJI is done, and the likelihood for infection is high, the next step is to refer the patient to an orthopedic surgeon. An orthopedic surgeon should be the team leader for treating PJI in an infected patient, and he/she should be the final person to diagnose PJI and provide subsequent treatment. Management of PJI patients should be a multidisciplinary approach, and infectious disease specialists play a central role in the treatment of PJI for determining the type, duration and length of antimicrobial treatment. The patient’s referral to an infectious disease specialist should be a decision from the orthopaedic surgeon managing the patient.

Do not prescribe physical therapy

A potential mistake is to treat the symptoms of pain without first knowing the underlying cause. Postoperative pain in a joint replacement is common in the first few months, and tends to improve after the first month. A trend is to order physical therapy in order to relieve non-specific pain, even after the first 6 postoperative months. This may be ineffective, since the physical recovery after a joint replacement is often achieved around 6 to 8 months after surgery [28]. If a patient’s recovery is abnormal, a complication must be suspected and a potential cause is a joint-related infection [10].

What to do

The following is a brief summary of the first recommendations from AAOS Clinical Practice Guidelines [21]. The guide provides a concise and simple workflow to diagnose PJI, but it should never replace a physician’s clinical judgment.

The first goal is to determine whether the patient has a low or high risk for PJI. This is performed by adding patient's symptoms, risk factors, physical examination, and radiographic findings together (Table 2 and Figure 2).

Presenting Symptoms Pain around the prosthetic joint and or stiffness
Evidence based Risk Factors Prior infected joint, associated infection around the prosthetic joint, high BMI, operative time over 2.5 hours, associated immune deficiency.
Consensus based Risk Factors Bacteremia or candidemia occurring one year preoperatively, simultaneous PJI, dermatologic pathologies*, intravenous drug abuse.
Physical Exam Findings Local inflammation signs: warmth, swelling or effusion. Draining sinus
Other findings Loosening occurring in less than 5 years postoperatively due to loosening. Seen in radiographs (Figure 1)

*Dermatologic pathologies: psoriasis, chronic cellulitis, lymphedema, chronic venous stasis, and skin ulcers

Table 2: Factors for Risk Stratification. Modified from AAOS: The Diagnosis of Periprosthetic Joint Infections of the Hip and Knee: Guideline and Evidence Report

family-medicine-medical-science-research-higher-lower-probability

Figure 2: Patients stratified into higher or lower probability of infection

If a patient has a high suspicion of PJI, the next step is to order serum CRP, serum ESR, and a set of plain radiographs of the involved joint. If these values are elevated without another source of infection, or if there are changes found on radiograph, these patients should be referred to an orthopedic surgeon. Ideally, patients should see the orthopedic surgeon that performed their index procedure. Secondarily, patients should be referred to an adult reconstructive surgeon who is well equipped for treating PJIs. These patients will then get joint aspirations, either under fluoroscopy or ultrasound for THA or in the clinic for TKA. If patients are determined to be infected, they will be taken to surgery and treated depending on the duration and presentation of their symptoms (Figure 3).

family-medicine-medical-science-research-workup-periprosthetic-joint

Figure 3: Algorithm for workup for periprosthetic joint infection

References

  1. Ethgen O, Bruyère O, Richy F, Dardennes C, Reginster JY (2004) Health-related quality of life in total hip and total knee arthroplasty. A qualitative and systematic review of the literature. J Bone Joint Surg Am 86-86A: 963-74.
  2. Chang RW, Pellisier JM, Hazen GB (1996) A cost-effectiveness analysis of total hip arthroplasty for osteoarthritis of the hip. JAMA 275: 858-865.
  3. Purbach B, Kay PR, Siney PD, Fleming PA, Wroblewski BM (2013) The C-stem in clinical practice: fifteen-year follow-up of a triple tapered polished cemented stem. J Arthroplasty 28: 1367-1371.
  4. Berry DJ, Harmsen WS, Cabanela ME, Morrey BF (2002) Twenty-five-year survivorship of two thousand consecutive primary Charnley total hip replacements: factors affecting survivorship of acetabular and femoral components. J Bone Joint Surg Am 84-84A: 171-7.
  5. Wroblewski BM, Fleming PA, Siney PD (1999) Charnley low-frictional torque arthroplasty of the hip. 20-to-30 year results. J Bone Joint Surg Br 81: 427-430.
  6. Coventry MB (1991) Foreword. In Amutz HC, ed. Hip arthroplasty. Churchill Livingstone, New York.
  7. Learmonth ID, Young C, Rorabeck C (2007) The operation of the century: total hip replacement. Lancet 370: 1508-1519.
  8. Pivec R, Johnson AJ, Mears SC, Mont MA (2012) Hip arthroplasty. Lancet 380: 1768-1777.
  9. Kurtz S, Ong K, Lau E, Mowat F, Halpern M (2007) Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 89: 780–85.
  10. ZmistowskiB, Restrepo C, Hess J, Adibi D, Cangoz S, et al. (2013) Unplanned readmission after total joint arthroplasty: rates, reasons, and risk factors. J Bone Joint Surg Am 95: 1869-1876.
  11. Ibrahim R (2013) Incidence and burden of periprosthetic Joint infections. In Parvizi J, periprosthetic Joint Infection: practical management guide. Jaypee brothers,Philadelphia
  12. Patil S, Garbuz DS, Greidanus NV, Masri BA, Duncan CP (2008) Quality of life outcomes in revision vs primary total hip arthroplasty: a prospective cohort study. J Arthroplasty 23: 550-553.
  13. Bozic KJ, Ries MD (2005) The impact of infection after total hip arthroplasty on hospital and surgeon resource utilization. J Bone Joint Surg Am 87: 1746-1751.
  14. Lavernia C, Lee DJ, Hernandez VH (2006) The increasing financial burden of knee revision surgery in the United States. ClinOrthopRelat Res 446: 221-226.
  15. Parvizi J, Zmistowski B, Berbari EF, Bauer TW, Springer BD, et al. (2011) New definition for periprosthetic joint infection: from the Workgroup of the Musculoskeletal Infection Society. ClinOrthopRelat Res 469: 2992-2994.
  16. Costerton JW, Stewart PS, Greenberg EP (1999) Bacterial biofilms: a common cause of persistent infections. Science 284: 1318-1322.
  17. Deirmengian C, Hallab N, Tarabishy A, Della Valle C, Jacobs JJ, et al. (2010) Synovial fluid biomarkers for periprosthetic infection. ClinOrthopRelat Res 468: 2017-2023.
  18. Nilsdotter-Augustinsson A, Briheim G, Herder A, Ljunghusen O, Wahlström O, et al. (2007) Inflammatory response in 85 patients with loosened hip prostheses: a prospective study comparing inflammatory markers in patients with aseptic and septic prosthetic loosening. ActaOrthop 78: 629-639.
  19. Di Cesare PE, Chang E, Preston CF, Liu CJ (2005) Serum interleukin-6 as a marker of periprosthetic infection following total hip and knee arthroplasty. J Bone Joint Surg Am 87: 1921-1927.
  20. Berbari E, Mabry T, Tsaras G, Spangehl M, Erwin PJ, et al. (2010) Inflammatory blood laboratory levels as markers of prosthetic joint infection: a systematic review and meta-analysis. J Bone Joint Surg Am 92: 2102-2109.
  21. Parvizi J, Della Valle CJ (2010) AAOS Clinical Practice Guideline: diagnosis and treatment of periprosthetic joint infections of the hip and knee. J Am AcadOrthopSurg 18: 771-772.
  22. Toossi N, Adeli B, Rasouli MR, Huang R, Parvizi J (2012) Serum white blood cell count and differential do not have a role in the diagnosis of periprosthetic joint infection. J Arthroplasty 27: 51-54.
  23. Trampuz A, Piper KE, Jacobson MJ, Hanssen AD, Unni KK, et al. (2007) Sonication of removed hip and knee prostheses for diagnosis of infection. N Engl J Med 357: 654-663.
  24. Parvizi J, Erkocak OF, Della Valle CJ (2014) Culture-negative periprosthetic joint infection. J Bone Joint Surg Am 96: 430-436.
  25. Marculescu CE, Berbari EF, Hanssen AD, Steckelberg JM, Harmsen SW, et al. (2006) Outcome of prosthetic joint infections treated with debridement and retention of components. Clin Infect Dis 42: 471-478.
  26. Tsukayama DT, Wicklund B, Gustilo RB (1991) Suppressive antibiotic therapy in chronic prosthetic joint infections. Orthopedics 14: 841-844.
  27. Rao N, Crossett LS, Sinha RK, Le Frock JL (2003) Long-term suppression of infection in total joint arthroplasty. ClinOrthopRelat Res : 55-60.
  28. Vissers MM, Bussmann JB, Verhaar JA, Arends LR, Furlan AD, et al. (2011) Recovery of physical functioning after total hip arthroplasty: systematic review and meta-analysis of the literature. PhysTher 91: 615-629.
Citation: Gomez MM, Manrique J, Chen AF (2014) Management of Infected Orthopedic Joint Implants: Pertinent Information for Family Medicine Physicians. Fam Med Med Sci Res 3:125.

Copyright: © 2014 Gomez MM, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Top